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Summary
Background and objectivesCKDandmultiple pregnancies bear important risks for pregnancy outcomes. The aim
of the study was to define the risk for adverse pregnancy-related outcomes in multiple pregnancies in CKD
patients in comparison with a control group of “low-risk” multiple pregnancies.
Design, setting, participants, & measurements The study was performed in the Maternal Hospital of the
University of Turin, Italy. Of 314 pregnancies referred in CKD (2000–2011), 20 were multiple (15 twin deliveries).
Control groups consisted of 379 low-risk multiple pregnancies (314 twin deliveries) and 19 (15 twin deliveries)
caseswith hypertension-collagen diseases. Baseline data and outcomeswere compared by univariate and logistic
regression analyses.
Results The prevalence of multiple pregnancies was relatively high in the CKD population (6.4%); all referred
cases were in early CKD stages (I-II); both creatinine (0.68 to 0.79 mg/dl; P50.010) and proteinuria (0.81 to 3.42 g/d;
P50.041) significantly increased from referral to delivery. No significant difference in demographic data at
baseline was found between cases and low-risk controls. CKD was associated with higher risk of adverse
pregnancy outcomes versus low-risk twin pregnancies. Statistical significance was reached for preterm delivery
(,34 weeks: 60% vs 26.4%; P50.005; ,32 weeks: 53.3% vs 12.7%; P,0.001), small for gestational age babies
(28.6% vs 8.1%; P,0.001), need for Neonatal Intensive Care Unit (60% vs 12.7%; P,0.001), weight discordance
between twins (40% vs 17.8%; P50.032), and neonatal and perinatal mortality (6.6% vs 0.8%; P50.032).
Conclusion This study suggests that maternal-fetal risks are increased in multiple pregnancies in the early CKD
stages.
Clin J Am Soc Nephrol 8: 41–50, 2013. doi: 10.2215/CJN.02550312
Introduction
Since the time of Cosmas andDamian (the twin brothers
personifying medicine and surgery), legends have at-
tributed both magic and danger to twins, in health and
disease. Thus, multiple pregnancies are known for their
high risks and relative unpredictability.
In the last few decades, so-called high-risk preg-
nancies have become more frequent and increasingly
recognized, mainly as a reflection of the advances in
maternal-fetal care. In spite of the growing interest,
our knowledge is still limited and little is known in
particular about the combination of several risk
factors. This is the case with multiple pregnancies in
CKD patients. Except for a few patients in the context
of larger series, only sporadic, exceptional cases have
been reported, many of which are in the context of
kidney transplantation (1–13). Most of the available
cases reported successful outcomes, presumably be-
cause of a baseline bias, probably a joint effect of the
comprehensible unwillingness to report patients
with a poor outcome, and of publication bias (1–13).
Multiple pregnancies are a growing challenge for at
least two reasons. First, the increase in maternal age
bears a higher incidence of twin pregnancy, especially
above the ages of 35 and 40 years. Second, the use of
assisted reproductive technologies, frequently using
multiple embryo transfer, has also increased (14,15).
Consequently, twin pregnancies have increased by
.50% and other multiple pregnancies (i.e., triplets,
quadruplets, etc.) by 400% in the Western world,
and the prevalence of twins, triplets, and quadruplets
has now reached 3% of all pregnancies (16). The in-
cidence of multiple pregnancies rises with parity, is
influenced by genetic factors, and differs among eth-
nic groups. For example, twins account for 1 in 1000
newborns in Japan and 50 in 1000 newborns in Ni-
geria (17,18).
Multiple pregnancies bear a three- to five-fold
higher risk of most maternal-fetal complications, in-
cluding pregnancy-induced hypertension, preeclamp-
sia, anemia, gestational diabetes, urinary tract
infections, and hemolysis, elevated liver enzymes,
low platelet count (HELLP) syndrome (19–22). The
risk for intrauterine death is at least four- to five-fold
higher than that recorded for singletons, along with the
risk of low weight, prematurity, and malformations
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(23–26). Dichorionic fraternal pregnancies account for
about 65%–70% of twin pregnancies, whereas monocho-
rionic or identical pregnancies account for the remainder
(27). The latter have specific and higher risks, particularly
if monoamniotic, and are often analyzed separately (17,27).
Pregnancy in CKD patients is a recognized challenge for
pregnancy-related outcomes and possibly also for the pro-
gression of CKD; because prevalence has been calculated as
high as 3% in women in childbearing age, the occurrence of
both CKD and multiple pregnancy can be considered rare
but not exceptional (expected in roughly 1 in 1000 preg-
nancies) (28–32). Because both multiple pregnancies and
CKD are acknowledged risk factors for adverse preg-
nancy-related outcomes, their combination can be expected
to represent an explosive mix, deserving particular attention
in the case of preconception counseling for assisted repro-
duction in CKD patients.
This study aimed to evaluate the outcomes recorded in
multiple pregnancies in CKDpatients observed and followed
in synergy in two multidisciplinary units, one dedicated to
CKD patients and the other to multiple pregnancies.
Materials and Methods
Study Setting and Inclusion Criteria
This study was conducted in the Maternal-Fetal Medi-
cine Unit of Sant’Anna University Hospital (150 beds for
obstetric patients) in Turin, Italy (29). The activity of the
unit is divided into different smaller units, including one
dedicated to CKD and one to multiple pregnancies. In
both units, main baseline and outcome data have been
gathered prospectively from the start of the activity. In
the CKD unit, the multidisciplinary team is composed of
nephrologists and obstetricians, and the activity started in
2000. This is the first series of multiple pregnancies ana-
lyzed from the archive, encompassing 314 pregnancies (20
multiple), with 233 singleton deliveries and 17 multiple
deliveries (15 twins and 2 triplets) as of December 31,
2011.
Multiple pregnancies with maternal or fetal risks have
been routinely followed by the Maternal-Fetal Unit since
1990. The outpatient unit dedicated to multiple pregnancies
started regular activity in 2004. The multidisciplinary team
consists of obstetricians, psychologists, and neonatologists.
As of June 2011, 649 multiple pregnancies were on file.
A maternal disease or an obstetric risk factor was re-
corded in 270 patients, whereas the remaining 379 were
low risk. Women were classified as “healthy women with
low-risk pregnancies” if they were not known to have any
of the medical or obstetric risk factors listed in the Na-
tional Institute for Clinical Excellence intrapartum care
guideline before the onset of labor (33,34). In the 270 pa-
tients with high-risk pregnancies, we recorded 6 therapeu-
tic terminations, 29 spontaneous abortions, 29 triplets, and
17 ongoing pregnancies. Thus, 189 twin deliveries with
risk factors were selected. Fifteen of the latter patients
were affected by CKD and 15 patients were affected by
conditions that may be considered at risk for CKD, includ-
ing hypertension and collagen disease. These patients
were selected as a second control group.
The remaining 159 twin deliveries were sorted into patients
affected by obstetric risk factors (26.4%) and maternal risk
factors (73.6%). In the latter subset, thyroid diseases accoun-
ted for 25.6%, thromboembolic risk for 10.25%, and infectious
diseases and cardiovascular problems for 9.4% each, whereas
psychiatric diseases, neurologic diseases, and obesity (with-
out hypertension) accounted for 5.1%, with the rest being
miscellaneous conditions.
In the low-risk group, there were 21 miscarriages, 35
triplet pregnancies, 3 quadruplet pregnancies, 6 pregnancy
terminations, and 314 twin deliveries, which served as
controls. To control for attrition biases, we tested a subset of
multiple pregnancies referred before the 12th gestational
week. However, because no significant difference was
recorded between early and late referrals, the comparison
took into account the overall noncomplicated twin pop-
ulation (35–38).
Definitions Utilized
Patients with CKD were stratified according to Kidney
Disease Outcomes Quality Initiative guidelines (36,37).
GFR calculation was based on preconception data and,
in their absence, on data at the first routine visit. The Cock-
croft and Gault formula was chosen because of the adjust-
ment for weight, partially accounting for underweight or
obesity, both of which were represented in our popula-
tion. Modified Diet in Renal Disease and Chronic Kidney
Disease Epidemiology Collaboration formulae were also
applied, controlling for patients that would have been clas-
sified otherwise. After referral, creatinine clearance on 24-
hour urine collection was considered as approximating
GFR; proteinuria was assessed on 24-hour urine collec-
tion (29).
Hypertension was defined as systolic BP $140 and/or
diastolic BP $90, or use of antihypertensive therapy (even
if present before conception) (29).
Preeclampsia was strictly defined as hypertension ac-
companied by proteinuria $300 mg/24 h after 20 weeks of
gestational age in a previously normotensive, nonprotein-
uric woman, in the absence of other signs or symptoms
indicating a different nephrologic diagnosis (39,40). As the
definition of superimposed preeclampsia is not unequivo-
cal, we did not include it in this study (40).
A newborn was defined as small for gestational age
(SGA) when the birth weight, adjusted for gestational age,
was below the 10th percentile according to Italian birth
weight references (32,41). Preterm delivery was defined as
delivery before 37 completed weeks of gestational age, and
early delivery was delivery before 34 completed weeks
(29,31,32). Twins were categorized as having a weight dis-
cordance when their estimated weight difference exceeded
20% (42,43).
Prenatal and Intrapartum Care
CKD patients with multiple pregnancies are usually
followed on alternate months in the CKD and multiple
pregnancy units, which work in close contact. One impor-
tant point in multiple pregnancies is the early definition of
chorionicity (within the 12th week) as the basis for
counseling on specific risks of the multiple pregnancies.
Thereafter, the patients follow the basic controls and visits
for multiple pregnancies, combined with those of CKD, as
described elsewhere in detail (29–32,35).
42 Clinical Journal of the American Society of Nephrology
Fetal ultrasounds and cardiotocography are performed
according to chorionicity (35). Delivery is planned, accord-
ing to the clinical status, between 37 and 38 gestational
weeks in dichorionic pregnancies and between 35 and 36
weeks in monochorionic diamniotic pregnancies. Mono-
chorionic monoamniotic and triplet pregnancies are an
indication for caesarean delivery and follow specific pro-
tocols; because no difference was found in our previous
series between spontaneous and assisted pregnancies, they
were analyzed together (35).
Hospitalization is required in the presence of poorly
controlled hypertension, worsening of renal function,
proteinuria of new onset or with rapid worsening, and
for any potentially severe problem of mother and/or
fetus (35). Indications for early delivery are severe wors-
ening of maternal conditions until 32 weeks, including
severe preeclampsia or HELLP syndrome, poorly con-
trolled hypertension, rapidly increasing nephrotic pro-
teinuria, or rapid increase in serum creatinine, alone or
in combination. Fetal worsening includes abnormal fetal
heart rate tracings at any gestational age, absent end di-
astolic flow velocities at Doppler study of the umbilical
arteries at or after 32 weeks of gestational age, or no fetal
growth over 2 weeks at later gestational ages. The main
indications for admission to the neonatal intensive care
unit (NICU) are birth weight ,1500 g, gestational age
,34 weeks, Apgar score ,7 at 59, or need for intubation
(29,35).
Figure 1. | Flowchart of the study population.
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Statistical Analyses
Both units keep a dedicated database; in both, the start of
observation is referral to the unit, whereas the end of ob-
servation is at the postpartum visit, 1 month after delivery.
The databases were merged at the 2011 updating.
Common parameters were analyzed in CKD patients in
comparison with the control group of low-risk multiple
pregnancies; analyses were limited to twins and were
performed separately for all patients and for dichorionic
pregnancies. Stratification included referral to the unit
before or after 12 weeks of gestational age, maternal age,
parity, nationality (Italian versus other), CKD stage, pro-
teinuria at referral, and spontaneous or induced pregnancy.
The main outcomes analyzed were caesarean section,
prematurity (cutpoints: 37, 34, and 32 weeks), gestational
week at delivery, weight, weight discordance .20%, prev-
alence of SGA, and need for hospitalization in the NICU.
Descriptive analyses were performed as appropriate
(mean 6 SD for parametric and median and range for
nonparametric data). The chi-squared test, Fisher’s test,
Kruskal–Wallis test, Mann–Whitney U test, ANOVA, and
t test with Bonferroni correction were used for compari-
sons between patients and controls and among groups.
Significance was set at ,0.05. Multivariate logistic regres-
sion analysis was used to control for simultaneous effects
of covariates. Adjusted odds ratios (ORs) and 95% confi-
dence intervals (95% CIs) were derived from the estimated
regression coefficients. Statistical evaluation was per-
formed using SPSS software for Windows (version 18.0;
SPSS Chicago, IL).
Results
Overall Data
The flowchart of the study population is shown in
Figure 1. In the study period (January 2000–December
2011), 314 pregnancies were observed in CKD patients;
the overall prevalence of multiple pregnancies (6%) was
high compared with the 3% prevalence reported in the
overall European population.
Table 1 reports the main clinical characteristics of the 20
pregnancies referred to our unit. Of note, all patients were
in the early CKD stages; however, counseling for interrup-
tion of multiple pregnancy in the context of more ad-
vanced CKD had not been performed in either unit. The
diagnoses are different and encompass all the main causes
of CKD in young patients. In three patients, diagnosis was
made in pregnancy. In an additional seven patients, a pre-
vious diagnosis of CKD had been overlooked with respect
to pregnancy. One patient was referred in the differential
diagnosis between preeclampsia and glomerular disease
(Table 1). No patient changed stage before delivery; a
trend toward increasing proteinuria was observed partic-
ularly in patients already proteinuric at baseline (Table 1).
Six patients underwent assisted fertilization for reasons
such as endometriosis, reduced ovarian reserve, oligo-
asthenospermia, and “idiopathic” causes.
Table 2 reports a baseline comparison between multiple
pregnancies in CKD, in low-risk pregnancies and in a
subset of patients at risk for CKD due to hypertension or
collagen disease. To note, there were no significant differ-
ences in baseline characteristics in CKD patients and con-
trols, except for the week of referral, occurring later in the
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unit dedicated to kidney diseases in pregnancy. The refer-
ral week was similar for patients with and without CKD in
the outpatient unit dedicated to twins; as a rule, the pa-
tients with CKD were referred earlier to the twins unit
(median week of referral, 13 weeks; range, 8–24) than to
the CKD unit (median week of referral, 22 weeks; range,
6–33). CKD was discovered in pregnancy in 10 of 20 pa-
tients; the two units work together and the patients are re-
ferred to the CKD unit after having performed blood and
urine tests and kidney ultrasounds, hence the delay between
first suspicion of CKD, diagnosis, and referral (Table 1). The
prevalence of assisted fertilization was similar in all subsets
(35) (Table 3). A baseline comparison between CKD and
controls, limited to dichorionic diamniotic pregnancies, is
also reported in Table 2. In spite of the lower number of
patients, the comparisons led to similar results.
Outcome Analyses
Table 3 reports the main outcomes of twin pregnancies
in CKD patients versus low-risk controls and versus pa-
tients with hypertension or collagen disease. The analysis
was performed considering all twin deliveries and limiting
the comparison to dichorionic diamniotic twins. In both
cases, the outcomes were worse in CKD patients. The
higher incidences of caesarean sections and of overall pre-
term deliveries (,37 weeks) did not reach statistical sig-
nificance over a high baseline level; however, a significant
difference was observed for all other major outcomes
(birth weight, SGA, weight discordance, early preterm de-
livery, need for NICU, risk of death).
The data recorded in the small group of patients with
maternal diseases at risk for CKD (hypertension and
collagen disease) suggested an intermediate risk pattern,
although statistical significance was not reached, perhaps
due to the small number of patients analyzed (Table 3).
Two perinatal deaths were recorded in the CKD group: a
male twin from a primiparous diabetic mother and a male
twin from a tertiparous mother with a not-yet-defined
familial nephropathy. The causes of death were cerebral
hemorrhage after correction of great vessel transposition in
patient 16 and infectious complication in patient 18; both
children were preterm. Five deaths were recorded in the
control group, and they were due to sepsis, respiratory
failure, and multiple malformations.
By definition, no patient with essential preexisting
hypertension was present in the low-risk group at baseline;
during pregnancy, 19 of 314 patients developed hyperten-
sion (6.05%) and 17 of 314 developed preeclampsia (5.41%).
HELLP syndrome occurred in 5 of 314 patients (1.59%). In
the subset with hypertension or collagen disease, 1 of 5
normotensive women developed hypertension, whereas
proteinuria developed in 7 of 10 patients with chronic
hypertension.
All of the CKD patients who were hypertensive at
referral (considering the first visit to either the twins unit
or the CKD unit) remained hypertensive throughout preg-
nancy; hypertension developed in four of nine previously
normotensive patients who delivered (44.44%).
Regarding kidney function, significant increases of both
serum creatinine and proteinuria were observed in this
small series of patients observed in the early CKD stages.
Serum creatinine increased from 0.68 to 0.79 (P=0.01); al-
though significant, the change was probably of scarce clin-
ical significance. Conversely, 24-hour proteinuria
showed a significant increase from 0.81 to 3.42 (P=0.04),
in spite of very dispersed data (Table 1).
The distinction between preeclampsia and other causes of
proteinuria or kidney disease may be impossible if addi-
tional data are not available. For example, patient 2 de-
veloped microhematuria, with red cell casts in the urine,
typical of IgA nephropathy and not typical of preeclampsia.
Multivariate Analyses
A logistic regression analysis was carried out for the three
outcomes that were significant in the univariate analysis
and had the greatest clinical relevance: “very early”
Table 2. Main baseline characteristics of low-risk controls, patients with either chronic hypertension or collagen disease, and CKD
patients
Low Risk (n=314) Chronic HTNor CD (n=15) CKD (n=15)
Age (yr) 32.265.33 33.567.67 32.563.64
BMI (kg/m2) 22.763.90 28.368.48
Nulliparous 188 (59.9) 8 (53.3)
Italian 214 (68.2) 13 (86.7)
Gestational week at first control 14 (6–34) 12 (9–29) Twins unit: 13 (8–24);
CKD unit: 22 (6–33)
Monochorionic diamniotic 93 (29.6) 5 (33.3)
Spontaneous pregnancies 240 (76.4) 13 (86.7)
Data are presented as mean 6 SD, n (%), or median (range). Twin pregnancies only; triplets are excluded. All twin pregnancies: 10
patientswith hypertension, 5with collagendisease; dichorionic diamniotic: 6 patientswith hypertension, 2with collagendisease.HTN,
hypertension; CD, collagen disease; BMI, body mass index.
aP values were calculated by ANOVA and t test with Bonferroni correction, chi-squared test, Fisher’s test, Kruskal–Wallis test, Mann–
Whitney U test. Statistical significance: P1, low-risk controls versus CKD patients; P2, low-risk controls versus patients with hyper-
tension and collagen disease; P3, patients with hypertension and collagen disease versus CKD patients.
bBMI: P2,0.05, P3,0.05; gestational week at first control: P1,0.01, P3,0.01.
cBMI: P2,0.05, P3,0.05; gestational week at first control: P1,0.05.
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preterm delivery (,32 completed gestational weeks), SGA
infant, and need for NICU. In spite of the relatively low
number of patients in the CKD cohort, the differences were
confirmed as statistically significant, with ORs ranging
from 4.35 (95% CI, 1.79–10.53) for SGA to 9.88 for NICU
(95% CI, 4.54–21.49) (Table 4).
Discussion
This study is the first to combine two high-risk situations,
multiple pregnancy and CKD, with the aim of character-
izing the risks as a guide for counseling and as help in the
decision-making process in CKD patients who choose to
undergo assisted fertilization techniques. Both situations
are present in about 3% of pregnancies; with the continuous
rise of multiple pregnancies and the higher awareness of
the importance of early stages of CKD in young patients,
this rare situation will presumably be encountered more
frequently in the future (14–16,44). In our study, the prev-
alence of multiple pregnancies was higher (6%) compared
with the European population; the particular attention to
clinical problems in twin pregnancies may have played a
role in enhancing referral.
Our study, conducted in the context of scarce information
and a series of generally positive case reports, demonstrates a
significant additional risk for adverse outcomes in multiple
pregnancies in CKD patients (1–13). On a baseline of rela-
tively high morbidity and mortality typical of multiple preg-
nancies, the availability of a large control group allowed
comparison with low-risk twin pregnancies, performed by
considering all twin pregnancies together or by limiting the
analysis to the more common subset of dichorionic dizygotic
twins (Table 2) (33,34). The cohort of at-risk multiple preg-
nancies was nonhomogeneous, combining both maternal
and obstetric risks of different severity; from this large
subset, a second, smaller control group was identified in
15 patients affected by diseases at risk for CKD (chronic
hypertension or collagen disease) (Table 2).
The three groups were homogeneous for all baseline
parameters, with the exception of week of referral (reflect-
ing the usual referral from the multiple pregnancy unit to
the nephrology unit) and of a high prevalence of patients in
which CKD was either diagnosed or taken into consider-
ation in pregnancy (10 of 20 patients) (Tables 1 and 2).
In this series of multiple pregnancies in CKD, all patients
were in the early CKD stages (Table 1). None of the pa-
tients changed CKD stage and the small but significant
increase in serum creatinine (0.68 at referral, 0.79 at deliv-
ery) was probably devoid of clinical significance, at least in
the medium term. Nevertheless, the increase in proteinuria
(from 0.80 to the nephrotic range) underlines the impor-
tance of closely monitoring this parameter over follow-up,
also after pregnancy.
The presence of CKD, regardless of the normal renal
function, significantly increased all of the major morbidity
indexes: early and very early preterm delivery, birth weight,
prevalence of SGA infants and need for NICU, an indirect
marker of the severity of the tested morbidity parameters.
Interestingly, the data recorded in the small group of patients
with hypertension or collagen disease suggest that patients at
risk for CKD may have an intermediate pattern (Table 3).
Within the limits of small numbers (not allowing statistical
significance), this observation suggests that the unfavorable
outcomes observed in CKD patients are not merely due to
hypertension or immune deregulation.
Our case series suggests an increase of perinatal mortality
in multiple pregnancies over and above the relatively high
background typical of twin pregnancies (Table 3) (14,18,21).
Once more within the limits of relatively small numbers,
the multivariate analysis comparing CKD patients and low-
risk controls allowed quantification of the ORs, which were
4.35 for SGA, 7.50 for delivery before 32 completed gesta-
tional weeks, and 9.88 for the need for NICU (Table 4).
The risks for adverse pregnancy outcomes are remarkably
different in singletons and twins with and without CKD
(29,31,32). However, our previous data in stage 1 singletons
indicated an OR of 8.99 for early preterm delivery, similar
to the OR of 7.5 for delivery before 32 weeks presently
found in twins, and an OR of 15.17 for need for NICU,
corresponding to an OR of 9.88 in twins (Table 4) (29).
The early rise of the risk for adverse pregnancy-related
events from the early stages of CKD is mostly unexplained,
like the increased risk of cardiovascular events from the
early stages of CKD. The relationship between kidney and
placenta is being clarified in typical preeclampsia, in which
placental ischemia leads to widespread activation/dys-
function of the maternal vascular endothelium via oxida-
tive stress and an imbalance between proangiogenic and
antiangiogenic factors (38–40,45–48). In our population,
we can postulate that the presence of even mild renal dam-
age may lower the threshold needed for evident endothe-
lial kidney damage in pregnancy and, conversely, that
factors of renal origin, thus far unknown, may affect the
placental circulation, particularly in the later stages of
pregnancy. The “larger” placentas of multiple pregnancies
could enhance these pathologic responses.
Our data have the limitations shared by all studies
dealing with a small sample size; however, this case series
Table 4. Results of the logistic regression analysis
OR (95% CI) P Value
Delivery before 32
completed
gestational
weeks
CKD 7.50 (2.53, 22.27) ,0.001
Age .30 yr 0.78 (0.38, 1.59) 0.49
Parity .1 0.58 (0.28, 1.19) 0.14
Non-Italian 1.05 (0.50, 2.20) 0.89
SGA
CKD 4.35 (1.79, 10.53) ,0.001
Age .30 yr 1.02 (0.54, 1.95) 0.92
Parity .1 0.90 (0.50, 1.61) 0.72
Non-Italian 0.93 (0.48, 1.77) 0.82
Need for NICU
CKD 9.88 (4.54, 21.49) ,0.001
Age .30 yr 0.97 (0.58, 1.64) 0.93
Parity .1 0.93 (0.58, 1.50) 0.78
Non-Italian 0.76 (0.44, 1.32) 0.34
OR, odds ratio; CI, confidence interval; SGA, small for gesta-
tional age; NICU, neonatal intensive care unit.
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of 20 CKD patients with multiple pregnancies is the largest
one available in the literature thus far. The importance of
our study is enhanced by the availability of a control group
uniformly followed in the same setting. Twin pregnancy
outcomes are highly dependent on the policies and settings
of care; thus, our study has the strength of a large control
group allowing the expression of the data in terms of ORs,
against a background of noncomplicated multiple preg-
nancies (Tables 3 and 4). Moreover, our data, obtained in a
setting dedicated to the care of high-risk pregnancies (both
for maternal diseases such as CKD and for obstetric reasons
such as multiple pregnancies), are the result of a combina-
tion of prenatal multidisciplinary care and baseline condi-
tions/diseases. An effect of referral of the most complicated
patients to tertiary care centers may have played a role in
increasing overall comorbidity and possibly in affecting
outcomes. A regional database for high-risk or multiple
pregnancies is needed to highlight this important point.
On these bases, we suggest that counseling for women
with CKD and a multiple pregnancy should underline the
higher risks of multiple pregnancies in CKD while admit-
ting that there is still not enough experience to precisely
quantify such risks. It should also be underlined that the
choice of a tertiary care center, more capable of dealing
with uncommon problems and complications, is probably
the most pragmatic approach for maternal-fetal care.
Assisted fertilization in CKD patients raises several issues
on the borderline between clinical and ethical aspects,
which are well beyond the scope of this analysis. They
regard the often difficult balance between the odds for
success with multiple implantation and the high risks
linked to multiple pregnancies in CKD patients. Our data
may indeed suggest that a policy of single embryo transfer
in CKD patients is safer with regard to maternal-fetal
outcomes. To note, in our small series, three of six patients
who underwent assisted fertilization were diagnosed with
CKD during pregnancy, suggesting that particular atten-
tion should be given to kidney diseases in the preliminary
evaluation for assisted fertilization techniques, including
renal ultrasounds and an evaluation of GFR, proteinuria,
and microscopic urinalysis in the work-up.
Further systematic long-term studies and possibly mul-
ticenter studies are needed to better define the risks; earlier
referral must be pursued in order to increase the diagnostic
accuracy and improve therapeutic interventions. The avail-
ability of a long-term follow-up of the children will greatly
help in overall counseling of CKD patients.
This study, the first aimed at assessing the risks of
multiple pregnancies in CKD patients, underlines the
importance of further investigation of the complex inter-
actions between CKD and pregnancy and suggests that
particular attention should be given to this potentially
explosive combination.
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